• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症免疫疗法的疗效因感染而受损。

The Efficacy of Cancer Immunotherapies Is Compromised by Infection.

机构信息

Service of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.

出版信息

Front Immunol. 2022 May 23;13:899161. doi: 10.3389/fimmu.2022.899161. eCollection 2022.

DOI:10.3389/fimmu.2022.899161
PMID:35677057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9168074/
Abstract

infects the gastric mucosa of a large number of humans. Although asymptomatic in the vast majority of cases, infection can lead to the development of peptic ulcers gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Using a variety of mechanisms, locally suppresses the function of the host immune system to establish chronic infection. Systemic immunomodulation has been observed in both clinical and pre-clinical studies, which have demonstrated that infection is associated with reduced incidence of inflammatory diseases, such as asthma and Crohn's disease. The introduction of immunotherapies in the arsenal of anti-cancer drugs has revealed a new facet of -induced immune suppression. In this review, we will describe the intimate interactions between and its host, and formulate hypothtyeses describing the detrimental impact of infection on the efficacy of cancer immunotherapies.

摘要

感染大量人类的胃黏膜。尽管在绝大多数情况下无症状,但感染可导致消化性溃疡、胃腺癌和黏膜相关淋巴组织(MALT)淋巴瘤的发生。通过多种机制,局部抑制宿主免疫系统的功能以建立慢性感染。临床和临床前研究均观察到系统免疫调节,表明感染与炎症性疾病(如哮喘和克罗恩病)发生率降低有关。免疫疗法在抗癌药物武器库中的引入揭示了 - 诱导免疫抑制的新方面。在这篇综述中,我们将描述与宿主之间的密切相互作用,并提出描述感染对癌症免疫疗法疗效的不利影响的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5340/9168074/9957e25dccf9/fimmu-13-899161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5340/9168074/8628e29d0f7c/fimmu-13-899161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5340/9168074/9957e25dccf9/fimmu-13-899161-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5340/9168074/8628e29d0f7c/fimmu-13-899161-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5340/9168074/9957e25dccf9/fimmu-13-899161-g002.jpg

相似文献

1
The Efficacy of Cancer Immunotherapies Is Compromised by Infection.癌症免疫疗法的疗效因感染而受损。
Front Immunol. 2022 May 23;13:899161. doi: 10.3389/fimmu.2022.899161. eCollection 2022.
2
[Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].[幽门螺杆菌感染及根除治疗对胃黏膜相关淋巴组织淋巴瘤的预后影响]
Korean J Lab Med. 2010 Dec;30(6):547-53. doi: 10.3343/kjlm.2010.30.6.547.
3
Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.胃微生物群:在幽门螺杆菌引起的胃部恶性肿瘤中崭露头角的新角色。
Cancer Lett. 2018 Feb 1;414:147-152. doi: 10.1016/j.canlet.2017.11.009. Epub 2017 Nov 11.
4
Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori.胃恶性肿瘤。胃黏膜相关淋巴组织淋巴瘤与幽门螺杆菌。
Gastroenterol Clin North Am. 2000 Sep;29(3):593-607. doi: 10.1016/s0889-8553(05)70132-1.
5
[Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma].幽门螺杆菌感染在胃癌及胃黏膜相关淋巴组织(MALT)淋巴瘤发病机制中的关键作用
Rinsho Byori. 2009 Sep;57(9):861-9.
6
Helicobacter pylori in gastric malignancies.胃恶性肿瘤中的幽门螺杆菌
Curr Gastroenterol Rep. 2012 Dec;14(6):489-96. doi: 10.1007/s11894-012-0296-y.
7
Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan.单纯幽门螺杆菌(HP)感染而非 HP 引起的萎缩性胃炎会增加胃癌的风险:日本的一项病例对照研究。
Ann Hematol. 2019 Aug;98(8):1981-1987. doi: 10.1007/s00277-019-03721-y. Epub 2019 Jun 8.
8
Gastric lymphoma of mucosa-associated lymphoid tissue and Helicobacter pylori.黏膜相关淋巴组织胃淋巴瘤与幽门螺杆菌
Annu Rev Med. 1998;49:289-99. doi: 10.1146/annurev.med.49.1.289.
9
Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma : relationship to cell death, proliferation, and transformation.细胞周期蛋白依赖性激酶2(cdc2)和细胞周期蛋白B1(cyclin B1)在幽门螺杆菌相关胃黏膜相关淋巴组织及胃黏膜相关淋巴组织淋巴瘤中的表达:与细胞死亡、增殖及转化的关系
Am J Pathol. 2000 Jan;156(1):217-25. doi: 10.1016/S0002-9440(10)64722-0.
10
Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma.胃黏膜相关淋巴组织淋巴瘤中的幽门螺杆菌感染
World J Gastroenterol. 2014 Mar 21;20(11):2751-9. doi: 10.3748/wjg.v20.i11.2751.

引用本文的文献

1
Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer.幽门螺杆菌感染对胃癌免疫检查点抑制剂疗效的影响。
BMC Cancer. 2025 Jul 1;25(1):1101. doi: 10.1186/s12885-025-14436-x.
2
infection negatively affects response of gastric cancer to immunotherapy.感染对胃癌免疫治疗的反应产生负面影响。
Ann Gastroenterol. 2025 May-Jun;38(3):262-269. doi: 10.20524/aog.2025.0966. Epub 2025 Apr 28.
3
Effect of infection on immunotherapy for gastrointestinal cancer: a narrative review.感染对胃肠道癌免疫治疗的影响:一项叙述性综述

本文引用的文献

1
TCR-T Immunotherapy: The Challenges and Solutions.TCR-T免疫疗法:挑战与解决方案
Front Oncol. 2022 Jan 25;11:794183. doi: 10.3389/fonc.2021.794183. eCollection 2021.
2
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells.分枝杆菌感染通过重定向新诱导的 Treg 细胞加重幽门螺杆菌诱导的胃前肿瘤病理。
Cell Rep. 2022 Feb 8;38(6):110359. doi: 10.1016/j.celrep.2022.110359.
3
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.
Immunotherapy. 2025 Apr;17(5):355-368. doi: 10.1080/1750743X.2025.2479410. Epub 2025 Mar 14.
4
Effects and mechanisms of on cancers development and immunotherapy.在癌症发生发展和免疫治疗中的作用及其机制。
Front Immunol. 2024 Oct 7;15:1469096. doi: 10.3389/fimmu.2024.1469096. eCollection 2024.
5
P53-associated lncRNAs regulate immune functions and RNA-modifiers in gastric cancer.P53相关的长链非编码RNA在胃癌中调节免疫功能和RNA修饰因子。
Heliyon. 2024 Jul 26;10(15):e35228. doi: 10.1016/j.heliyon.2024.e35228. eCollection 2024 Aug 15.
6
Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis.胃癌与胃微生物群研究的全球现状及趋势:一项文献计量分析
Front Microbiol. 2024 Apr 9;15:1341012. doi: 10.3389/fmicb.2024.1341012. eCollection 2024.
7
Role of Helicobacter pylori virulence factors and alteration of the Tumor Immune Microenvironment: challenges and opportunities for Cancer Immunotherapy.幽门螺杆菌毒力因子的作用与肿瘤免疫微环境的改变:癌症免疫治疗面临的挑战与机遇
Arch Microbiol. 2024 Mar 15;206(4):167. doi: 10.1007/s00203-024-03908-6.
8
Cross-talk between and gastric cancer: a scientometric analysis.和胃癌之间的串扰:一项科学计量学分析。
Front Cell Infect Microbiol. 2024 Jan 31;14:1353094. doi: 10.3389/fcimb.2024.1353094. eCollection 2024.
9
Helicobacter pylori testing prior to or at gastric cancer diagnosis and survival in a diverse US patient population.在美国不同患者人群中,在胃癌诊断前或诊断时进行幽门螺杆菌检测与生存情况的关系。
Gastric Cancer. 2024 Jan;27(1):28-35. doi: 10.1007/s10120-023-01448-4. Epub 2023 Nov 20.
10
The role of microbiota in the development and treatment of gastric cancer.微生物群在胃癌发生发展及治疗中的作用。
Front Oncol. 2023 Sep 29;13:1224669. doi: 10.3389/fonc.2023.1224669. eCollection 2023.
色氨酸衍生的微生物代谢物激活肿瘤相关巨噬细胞中的芳香烃受体,从而抑制抗肿瘤免疫。
Immunity. 2022 Feb 8;55(2):324-340.e8. doi: 10.1016/j.immuni.2022.01.006.
4
Influence of Helicobacter pylori infection on PD-1/PD-L1 blockade therapy needs more attention.幽门螺杆菌感染对 PD-1/PD-L1 阻断治疗的影响需要更多关注。
Helicobacter. 2022 Apr;27(2):e12878. doi: 10.1111/hel.12878. Epub 2022 Feb 3.
5
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy.靶向代谢型谷氨酸受体4用于癌症免疫治疗。
Sci Adv. 2021 Dec 10;7(50):eabj4226. doi: 10.1126/sciadv.abj4226.
6
Chinese Consensus Report on Family-Based Infection Control and Management (2021 Edition).中国家族性感染防控与管理专家共识(2021 年版)
Gut. 2022 Feb;71(2):238-253. doi: 10.1136/gutjnl-2021-325630. Epub 2021 Nov 26.
7
in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes.在人类胃中:临床结果的不一致性及可能原因。
Front Microbiol. 2021 Aug 17;12:713955. doi: 10.3389/fmicb.2021.713955. eCollection 2021.
8
Helicobacter urease suppresses cytotoxic CD8+ T-cell responses through activating Myh9-dependent induction of PD-L1.幽门螺旋杆菌脲酶通过激活 Myh9 依赖性 PD-L1 诱导来抑制细胞毒性 CD8+T 细胞反应。
Int Immunol. 2021 Aug 23;33(9):491-504. doi: 10.1093/intimm/dxab044.
9
infection has a detrimental impact on the efficacy of cancer immunotherapies.感染对癌症免疫疗法的疗效有不利影响。
Gut. 2022 Mar;71(3):457-466. doi: 10.1136/gutjnl-2020-323392. Epub 2021 Jul 12.
10
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.肠道微生物组和微生物衍生代谢物在癌症免疫检查点阻断免疫治疗中的作用。
Genome Med. 2021 Jun 23;13(1):107. doi: 10.1186/s13073-021-00923-w.